首页 › 基金 › Nepsis Inc. › HCAT
Nepsis Inc. 对 HCAT 的持仓历史
HEALTH CATALYST INC · 信息技术
Nepsis Inc. 在 Q3 2026 的 13F 申报中披露持有 HCAT(HEALTH CATALYST INC)2,989,705 股,市值约 US$5.2M,约占其申报组合的 1.63%,在其申报持仓中市值排名第 22 位。 Nepsis Inc. 最近 13 个申报季度中有 13 个季度披露了 HCAT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-15 · 来源: SEC EDGAR Form 13F-HR
Nepsis Inc. 对 HCAT 的持仓演变
Nepsis Inc. 于 Q3 2023 首次披露 HCAT 持仓:905,804 股(约 US$9.2M)。 该持仓在 Q3 2024 达到峰值 2,104,528 股,市值约 US$17.1M。 在 13 次申报中,Nepsis Inc. 7 次增持、4 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 2,989,705 股、市值约 US$5.2M。 持仓曾出现大幅变动:Q3 2024 增持约 68% (随后一个季度股价下跌 13%)、Q4 2024 减持约 95% (随后一个季度股价下跌 36%)、Q1 2025 增持约 2072% (随后一个季度股价下跌 17%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 905.80K | $9.17M | 新进 |
| Q4 2023 | 1.09M | $10.11M | 增持 |
| Q1 2024 | 1.16M | $8.72M | 增持 |
| Q2 2024 | 1.25M | $8.01M | 增持 |
| Q3 2024 | 2.10M | $17.13M | 增持 |
| Q4 2024 | 96.26K | $10.12M | 减持 |
| Q1 2025 | 2.09M | $9.47M | 增持 |
| Q2 2025 | 1.73M | $6.50M | 减持 |
| Q3 2025 | 1.51M | $4.31M | 减持 |
| Q4 2025 | 1.92M | $4.58M | 增持 |
| Q1 2026 | 1.88M | $2.38M | 减持 |
| Q2 2026 | 2.98M | $5.92M | 增持 |
| Q3 2026 | 2.99M | $5.17M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HCAT 与 13F 数据
HCAT(HEALTH CATALYST INC)属于信息技术行业。我们追踪的基金中还有 7 只申报持有 HCAT,申报仓位最大的包括:First Light Asset Management, LLC (US$25.5M), CDC Financial, Inc. (US$14.1M), Palogic Value Management, L.P. (US$9.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HCAT 的基金
- First Light Asset Management, LLC 12.81M 股 · $25.49M · Q2 2026
- CDC Financial, Inc. 7.09M 股 · $14.11M · Q2 2026
- Palogic Value Management, L.P. 4.92M 股 · $9.80M · Q2 2026
更多关于 Nepsis Inc.
常见问题
How long has Nepsis Inc. held HCAT?
Nepsis Inc. has disclosed HCAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nepsis Inc.'s current position in HCAT?
As of Q3 2026, Nepsis Inc. holds 2.99M shares of HCAT (HEALTH CATALYST INC), valued at $5.17M, representing 1.63% of its reported portfolio and ranking #22.
Has Nepsis Inc. been buying or selling HCAT?
In the latest 13F filing (Q3 2026), Nepsis Inc. held unchanged its position in HCAT. The position peaked in Q3 2024 at 2.10M shares.
Which other funds hold HCAT?
Other major institutional holders of HCAT include First Light Asset Management, LLC, CDC Financial, Inc., Palogic Value Management, L.P., among 7 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.